Parsec Financial Management, Inc. Geron Corp Transaction History
Parsec Financial Management, Inc.
- $2.37 Billion
- Q1 2023
A detailed history of Parsec Financial Management, Inc. transactions in Geron Corp stock. As of the latest transaction made, Parsec Financial Management, Inc. holds 15,000 shares of GERN stock, worth $20,250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,000
Previous 17,335
13.47%
Holding current value
$20,250
Previous $41,000
21.95%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding GERN
# of Institutions
282Shares Held
509MCall Options Held
884KPut Options Held
564K-
Ra Capital Management, L.P. Boston, MA60.4MShares$81.5 Million1.86% of portfolio
-
Black Rock Inc. New York, NY46.6MShares$62.8 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT43MShares$58.1 Million2.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA35.6MShares$48.1 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$36.8 Million8.13% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $510M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...